• AGIO Down 17.9%

    Agios falls 18% as FDA delays sickle cell decision over safety review

    Agios fell about 18% after the FDA pushed its decision on mitapivat for sickle cell disease to Feb 1, 2027, while it weighs whether a safety program is needed.

    3 min read · Biotech
  • CACC Down 19.3%

    Credit Acceptance falls 19% as it cuts its loan cash-flow forecast

    Credit Acceptance's adjusted earnings topped estimates, but it cut its forecast of loan net cash flows by $291 million, producing a loss under standard accounting.

    5 min read · Financial Services
  • ILMN Down 18.6% UPDATED OCT 31

    Illumina falls 19% even as it raises its full-year forecast

    Illumina shares fell after earnings despite a forecast raise. Tariff-related customer credits complicate the reported revenue miss.

    5 min read · Health care